Published in Neuroscience on December 08, 2007
Presynaptic 5-HT(1B) receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis. Neuroscience (2009) 0.89
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain (2008) 0.86
Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. Front Neural Circuits (2014) 0.84
Presynaptic serotonergic gating of the subthalamonigral glutamatergic projection. J Neurosci (2013) 0.78
Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology. Exp Brain Res (2013) 0.77
Primate models of movement disorders of basal ganglia origin. Trends Neurosci (1990) 7.63
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science (1990) 3.74
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain (2007) 2.49
Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res (1994) 2.21
Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci (2004) 1.77
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol (1995) 1.72
The functional anatomy of disorders of the basal ganglia. Trends Neurosci (1995) 1.62
The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol (1994) 1.38
Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers. Proc Natl Acad Sci U S A (1992) 1.32
Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol (2000) 1.31
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.28
Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J Physiol (1985) 1.24
The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience (1994) 1.24
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience (1999) 1.18
5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci (1992) 1.17
Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17
Presynaptic inhibition of glutamatergic synaptic transmission to rat motoneurons by serotonin. J Neurophysiol (1996) 1.14
Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.13
Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci (1996) 1.09
Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res (1990) 1.08
Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus. J Physiol (1996) 1.02
5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(1A) receptors. Neuropharmacology (2005) 0.99
Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors. Eur J Neurosci (1998) 0.95
Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Res (2001) 0.95
Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes. J Neurophysiol (2005) 0.92
Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. Eur J Neurosci (1996) 0.89
Tolerance to the serotonin 5-HT1 agonist RU 24969 and effects on dopaminergic behaviour. Eur J Pharmacol (1987) 0.89
5-Hydroxytryptamine 1B receptors mediate presynaptic inhibition of monosynaptic IPSC in the rat dorsolateral septal nucleus. Neurosci Res (2004) 0.86
Subthalamic 5-HT(1A) and 5-HT(1B) receptor modulation of RU 24969-induced behavioral profile in rats. Pharmacol Biochem Behav (2002) 0.84
Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons. Neuroscience (2007) 0.84
Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain. Neuropharmacology (2000) 0.83
Immunohistochemical demonstration of serotonin nerve fibers in the subthalamic nucleus of the rat, cat and monkey. Neurosci Lett (1985) 0.79
Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets. Pharmacol Biochem Behav (2004) 0.78
Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene (1999) 2.20
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. Biochem Pharmacol (2000) 1.58
The biology of ovarian cancer. Semin Oncol (1998) 1.46
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br J Cancer (2005) 1.42
Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol (2000) 1.31
Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons. Neurosci Lett (1992) 1.30
The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res (2000) 1.27
Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group. J Clin Oncol (1996) 1.21
GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci (2001) 1.20
Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J Physiol (1997) 1.11
Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res (1995) 1.11
Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol Sci (1999) 1.11
Measuring quality of care in psychiatric emergencies: construction and evaluation of a Bayesian index. Health Serv Res (1993) 1.04
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule. Cancer Res (1994) 1.03
Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res (1993) 1.01
Dopamine receptors set the pattern of activity generated in subthalamic neurons. FASEB J (2005) 0.96
Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci (1995) 0.94
Clinical pharmacokinetics and administration of established platinum drugs. Drugs (2000) 0.94
Effects of anoxia on rat midbrain dopamine neurons. J Neurophysiol (1994) 0.92
Influences of electrode geometry on bipolar recordings of the surface electromyogram. Med Biol Eng Comput (1978) 0.92
Miniature skin-mounted preamplifier for measurement of surface electromyographic potentials. Med Biol Eng Comput (1977) 0.92
Translocation and activation of AKT2 in response to stimulation by insulin. J Cell Biochem (1998) 0.91
Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J Pharmacol Exp Ther (1995) 0.90
Gene expression profiling of human ovarian tumours. Br J Cancer (2006) 0.90
Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res (1994) 0.87
Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice. J Pharmacol Exp Ther (1996) 0.86
Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J Pharmacol Exp Ther (1998) 0.86
Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons. Neuroscience (2007) 0.84
Sulfonylurea-sensitive potassium current evoked by sodium-loading in rat midbrain dopamine neurons. Neuroscience (1996) 0.83
Presynaptic inhibition of synaptic transmission by adenosine in rat subthalamic nucleus in vitro. Neuroscience (2003) 0.82
Presynaptic GABA(B) receptors inhibit synaptic inputs to rat subthalamic neurons. Neuroscience (2001) 0.82
Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience (1994) 0.82
Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel. Clin Cancer Res (1996) 0.81
Potentiation of GABA(A) receptor agonists by GABA uptake inhibitors in the rat ventral midbrain. Eur J Pharmacol (2001) 0.81
A slow excitatory postsynaptic current mediated by G-protein-coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. Eur J Neurosci (1997) 0.80
Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons. Neuroscience (2011) 0.80
Presynaptic dopaminergic activity of phencyclidine in rat caudate. J Pharmacol Exp Ther (1984) 0.80
Metabotropic glutamate and muscarinic cholinergic receptor-mediated preferential inhibition of N-methyl-D-aspartate component of transmissions in rat ventral tegmental area. Neuroscience (2003) 0.80
Correlation of mutagenic and dermal carcinogenic activities of mineral oils with polycyclic aromatic compound content. Fundam Appl Toxicol (1988) 0.80
Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons. Br J Pharmacol (1999) 0.79
Glycine receptor-mediated inhibition of dopamine and non-dopamine neurons of the rat ventral tegmental area in vitro. Brain Res (2001) 0.79
The chemopreventive agent oltipraz stimulates repair of damaged DNA. Cancer Res (1997) 0.79
Sodium pump evokes high density pump currents in rat midbrain dopamine neurons. J Physiol (1998) 0.79
Dual modulation of gabaergic transmission by metabotropic glutamate receptors in rat ventral tegmental area. Neuroscience (2003) 0.78
Sulfonylureas enhance GABAA synaptic potentials in rat midbrain dopamine neurones. Acta Physiol Scand (1996) 0.78
Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology (1983) 0.78
Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin. Cancer Chemother Pharmacol (1996) 0.78
Nitric oxide facilitates N-methyl-D-aspartate-induced burst firing in dopamine neurons from rat midbrain slices. Neurosci Lett (1998) 0.77
Norepinephrine-dependent and independent mechanisms of persistent effects of amphetamine in rat cerebellum. Life Sci (1985) 0.77
Growth regulation of ovarian cancer. Hematol Oncol Clin North Am (1992) 0.77
Correlation of Purkinje neuron depression and hypnotic effects of ethanol in inbred strains of rats. Alcohol Clin Exp Res (1985) 0.76
Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers. Mol Pharmacol (1999) 0.76
Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate. J Neurosci (1986) 0.76
Hydrolysis of fucosyl-GM1 ganglioside by purified pellet-associated human brain and human liver alpha-L-fucosidases without activator proteins or detergents. Biochem J (1990) 0.76
Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochem Pharmacol (1999) 0.76
Analysis of the subunits, isoforms and substrate specificity of mouse liver alpha-L-fucosidase. Comp Biochem Physiol B (1993) 0.76
DNA binding activity of the mammalian translation elongation complex: recognition of chromium- and transplatin-damaged DNA. Arch Toxicol (1997) 0.75
Persistent effects of amphetamine on cerebellar Purkinje neurons following chronic administration. Brain Res (1982) 0.75
Ability of periaqueductal gray subdivisions and adjacent loci to elicit analgesia and ability of naloxone to reverse analgesia. Behav Neurosci (1989) 0.75
Client counseling in orthopedic emergencies. Vet Clin North Am Small Anim Pract (1995) 0.75
The use of a stirring wheel in the study of patterns of arm and trunk movements in normal subjects and hemiplegic patients [proceedings]. J Physiol (1977) 0.75
Prolonged exposure to mine tailings and survival and reproductive success of ovigerous tanner crabs (Chionoecetes bairdi). Bull Environ Contam Toxicol (1998) 0.75
The solubility of phenytoin in a physiological salt solution. Methods Find Exp Clin Pharmacol (1980) 0.75
Molecular biology of gynecologic malignancies. Cancer Treat Res (1998) 0.75
Survival, growth, and bioaccumulation of heavy metals by juvenile Tanner crabs (Chionoecetes bairdi) held on weathered mine tailings. Bull Environ Contam Toxicol (1997) 0.75
A comparative study of the effects of phenytoin and phenobarbital on electrically induced maximal seizures in frogs and mice. J Pharmacol Exp Ther (1982) 0.75
Acquisition and analysis of electromyographic data associated with dynamic movements of the arm. Med Biol Eng Comput (1980) 0.75
Metabolism, tissue distribution, and elimination kinetics of phenytoin in the frog. Drug Metab Dispos (1983) 0.75
Phenytoin antagonism of electrically induced maximal seizures in frogs and mice and effects on central nervous system levels of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. J Pharmacol Exp Ther (1982) 0.75
A skin-mounted preamplifier for recording the surface electromyogram (e.m.g.) [proceedings]. J Physiol (1977) 0.75
Recent insights into drug resistance in ovarian cancer. Methods Mol Med (2001) 0.75
Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cells. Gynecol Oncol (1995) 0.75
Structure-activity relationships of phencyclidine derivatives in rat cerebellum. Pharmacol Biochem Behav (1986) 0.75
Dose-response analysis of phenytoin on electrically induced seizures and spontaneous activity of cerebellar purkinje cells in the frog. Epilepsia (1982) 0.75
Anticonvulsant effects of acute and chronic phenytoin treatment in Rana pipiens. Proc West Pharmacol Soc (1980) 0.75
Apollo 12 lunar module impact: laboratory simulation and possible downrange ballistic effects. Science (1970) 0.75
Antagonism of metrazol-induced convulsions by sodium bromide in Rana pipiens. Proc West Pharmacol Soc (1977) 0.75
Role of the medical oncology social worker. Ariz Med (1977) 0.75
Effects of d-amphetamine withdrawal in rats and man. Am J Psychiatry (1983) 0.75
L-arginine potentiates GABA-mediated synaptic transmission by a nitric oxide-independent mechanism in rat dopamine neurons. Neuroscience (1997) 0.75
Mutual expectations. How family members view the social role of the mental health center client. J Psychosoc Nurs Ment Health Serv (1986) 0.75
Identification of the stretch reflex using pseudorandom excitation: electromyographic response to displacement of the human forearm. Med Biol Eng Comput (1981) 0.75
Quality assurance for psychiatric emergencies. An analysis of assessment and feedback methodologies. Psychiatr Clin North Am (1990) 0.75
Leisure: how to promote inpatient motivation after discharge. J Psychosoc Nurs Ment Health Serv (1989) 0.75
Reflex electromyographic response to random limb displacement [preceedings]. J Physiol (1979) 0.75